. 2017 Jan-Feb;11(1):204–214. doi: 10.1016/j.jacl.2016.12.007

Table 2.

Adjusted factors associated with suboptimal statin occurrence

Risk factor	Suboptimal statin therapy, n (%)	Constant statin users, n (%)	Multivariable analysis
Risk factor	Suboptimal statin therapy, n (%)	Constant statin users, n (%)	OR (95% CI)	P value
Muscular symptoms	5 (3.2)	7 (0.8)	4.28 (1.30–14.08)	.017
Sex (female vs male)	M: 102 (65.4)	M: 660 (77.4)	1.75 (1.14–2.68)	.010
P2Y₁₂ inhibitor at V2	122 (78.2)	738 (86.9)	0.53 (0.34–0.84)	.007
Beta blocker at V2	119 (76.3)	725 (85.4)	0.59 (0.36–0.96)	.036

CI, confidence interval; OR, odds ratio.

Covariates with univariate P < .1 were entered into multivariable logistic regression modeling using a forward likelihood ratio method to select the multivariable model presented here.